According to 2006 American Diabetes Association’s recommendation, SMBG is regarded as an essential aspect of diabetes management in insulin-treated patients and a desirable aspect in non-insulin treated patients with diabetes [45]. This evidence concerns the gene INS and diabetes mellitus.